Advancing immunotherapy via multiple immune cells co-engagement.

Area of Science:

• Immunology
• Oncology
• Biotechnology

Background:

• Immunotherapy has achieved significant clinical success in treating various cancers due to its specificity and lasting effects.
• The tumor microenvironment (TME) presents complex challenges that limit immunotherapy efficacy.
• Current strategies often focus on engaging single immune cell types, such as T cells and NK cells.

Purpose of the Study:

• To review current single immune cell engagers.
• To explore next-generation immunotherapies that co-engage multiple immune cell types.
• To discuss targets, mechanisms, and design principles for these advanced therapies.

Main Methods:

• Literature review of existing immune cell engagers.
• Analysis of emerging strategies for multiple immune cell co-engagement.
• Discussion of therapeutic design considerations for novel immunotherapies.

Main Results:

• Overview of single immune cell-targeting immunotherapies.
• Identification of key targets and mechanisms for multiple immune cell co-engagement.
• Exploration of design principles for synergistic immune cell activation.

Conclusions:

• Co-engagement of multiple immune cells in the TME is a promising frontier for cancer immunotherapy.
• Addressing TME complexities requires innovative strategies beyond single-cell targeting.
• Further research into multiple immune cell co-engagers holds potential for overcoming current therapeutic limitations.